EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [177Lu]Lu-PSMA-617 Radioligand Therapy

Dheeratama Siripongsatian iD, Attapon Jantarato, Chetsadaporn Promteangtrong, Anchisa Kunawudhi, Peerapon Kiatkittikul, Natphimol Boonkawin, Sukanya Yaset, Sirinsuda Somboon, Chanisa Chotipanich

Indian Journal of Radiology and Imaging · 01.10.2024 · 34 (04) · 579-587

DOI: 10.1055/s-0044-1779634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Radiology and Imaging, erschienen am 01.10.2024. Verfasst von Dheeratama Siripongsatian und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective [177Lu]Lu-prostate-specific membrane antigen (PSMA)-617 radioligand therapy (RLT) shows promise for metastatic castration-resistant prostate cancer (mCRPC) patients with positive PSMA positron emission tomography (PET) imaging. Identifying high-risk patients is crucial. We evaluated pretherapeutic PSMA PET-derived parameters to predict prostate-specific antigen (PSA) response in patients undergoing [177Lu]Lu-PSMA-617 RLT. Materials and Methods We conducted a retrospective analysis among 27 patients (mean age: 71.0 ± 9.5 years; range: 52–85 years) who underwent PSMA PET/computed tomography (CT) and subsequent [177Lu]Lu-PSMA-617 RLT between March 2019 and January 2023. After excluding patients with liver metastases, the number of patients left for analysis was 21 (14 responders and 7 nonresponders). Tumors were semiautomatically delineated with calculation of total tumor volume (PSMA-TV), lesion uptake (PSMA-TLU = PSMA-TV * standardized uptake value [SUV]mean), and lesion quotient (PSMA-TLQ = PSMA-TV/SUVmean) for each patient. Semiquantitative parameters were analyzed only in patients with mCRPC and no liver metastasis.

Results

In total, 17/27 patients (62.96%) had a decline in PSA levels; 15/27 patients (55.56%) experienced a decline of > 50%. Pretherapeutic PSMA PET/CT results revealed significant differences in PSMA-TV (p = 0.003), PSMA-TLU (p = 0.013), and PSMA-TLQ (p = 0.011) between responders and nonresponders. SUVmax was significantly correlated to the best percentage change in PSA response after 177Lu-PSMA-617 treatment (r = −0.79, p = 0.006). No association was observed between PSMA-TV (p = 0.367), PSMA-TLU (p = 0.128), and PSMA-TLQ (p = 0.556), with the best percentage change in PSA response after 177Lu-PSMA-617 therapy.

Conclusion

Pretherapeutic PSMA PET-derived PSMA-TV, PSMA-TLU, and PSMA-TLQ were significant negative predictors of PSA response in patients with mCRPC and no liver metastasis receiving [177Lu]Lu-PSMA-617 RLT.

Schlagwörter

Stichwörter der Autor:innen

[ 177 Lu]Lu-PSMA-617liver metastasismetastatic castration-resistant prostate cancerpretherapeutic PSMA PETradioligand therapy

Autor:innen und Institutionen

  • National Cyclotron and PET Centre, Chulabhorn Hospital, Bangkok, Thailand.

ORCID-Profile: Dheeratama Siripongsatian

Zitieren

APA

Siripongsatian, D., Jantarato, A., Promteangtrong, C., Kunawudhi, A., Kiatkittikul, P., Boonkawin, N., Yaset, S., Somboon, S., & Chotipanich, C. (2024). Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [177Lu]Lu-PSMA-617 Radioligand Therapy. Indian Journal of Radiology and Imaging, 34(04), 579-587. https://doi.org/10.1055/s-0044-1779634

Vancouver

Siripongsatian D, Jantarato A, Promteangtrong C, Kunawudhi A, Kiatkittikul P, Boonkawin N, et al. Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [177Lu]Lu-PSMA-617 Radioligand Therapy. Indian Journal of Radiology and Imaging. 2024;34(04):579-587. doi:10.1055/s-0044-1779634

BibTeX
@article{Siripongsatian2024,
  author = {Siripongsatian, Dheeratama and Jantarato, Attapon and Promteangtrong, Chetsadaporn and Kunawudhi, Anchisa and Kiatkittikul, Peerapon and Boonkawin, Natphimol and Yaset, Sukanya and Somboon, Sirinsuda and Chotipanich, Chanisa},
  title = {Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [177Lu]Lu-PSMA-617 Radioligand Therapy},
  journal = {Indian Journal of Radiology and Imaging},
  year = {2024},
  volume = {34},
  number = {04},
  pages = {579--587},
  doi = {10.1055/s-0044-1779634}
}
Kostenlos starten →